- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Multiple Myeloma: Front Line Therapy and Autologous Stem Cell Transplantation ; volume:54 ; number:02 ; year:2018 ; pages:096-105
Annals of National Academy of Medical Sciences (India) ; 54, Heft 02 (2018), 096-105
- Contributor
-
Kumar, Lalit
- DOI
-
10.1055/s-0040-1712792
- URN
-
urn:nbn:de:101:1-2020070907512785098448
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kumar, Lalit
Other Objects (12)
Current status of autologous stem cell transplantation for multiple myeloma
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Current status of autologous stem cell transplantation for multiple myeloma
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Current status of autologous stem cell transplantation for multiple myeloma
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma